Future Clinical Trials Consulting

Executive Summary

Future Clinical Trials Consulting is a boutique consulting firm based in Zurich, Switzerland, founded in 2018 by an MD/PhD and former GSK Senior Medical Director. The company offers independent Medical Monitoring, Safety Oversight, and Clinical Strategy services tailored for biotech sponsors and CROs. Its core value proposition is direct accountability with no handoffs, ensuring seamless, expert oversight throughout clinical development. With deep expertise in Phase 3 programs, the firm fills a critical gap for sponsors seeking high-quality, independent medical oversight without the overhead of large CROs. The company's lean model and founder-led approach resonate in an era where regulatory scrutiny is intensifying and the complexity of global trials demands specialized, hands-on expertise. Given its small scale and niche focus, Future Clinical Trials Consulting is well-positioned to capture growing demand for independent medical monitoring, particularly among mid-size biotechs. However, scaling will depend on expanding its client base beyond referrals into larger pharma and CRO partnerships. The company's reputation and track record of direct, high-stakes involvement in Phase 3 milestones provide a strong foundation. Key growth drivers include securing contracts with top-tier pharma, developing digital tools to streamline oversight, and forming strategic alliances with CROs to embed its services. While the consulting market is competitive, the firm's unique positioning as a no-handoff, senior-led provider creates a defensible niche.

Upcoming Catalysts (preview)

• Q4 2026Securing a major pharma contract for Phase 3 trial medical monitoring60% success
• Q2 2027Launch of digital clinical oversight platform50% success
• Q3 2026Strategic partnership with a top CRO65% success